DaBomb Protein Biotech (6578) Monthly Revenue

Market: TPEx (OTC) · Industry: Agritech · 達邦蛋白

DaBomb Protein Biotech (6578) reported revenue of NT$40.1 million for Oct 2026, +45.4% year on year and +15.9% from the previous month. Revenue for Jan–Oct 2026 was NT$336 million (+31.2% year on year).

Revenue for Oct 2026 was a record high (previous high: Apr 2024, NT$39.9 million). →

Year-on-year revenue growth: 6 months in a row. →

In Oct 2026, it ranked No. 3 by revenue among 4 Agritech companies.

Monthly revenue chart

Oct 2024 NT$30.1 million24/10Nov 2024 NT$35.1 millionDec 2024 NT$16.5 millionJan 2025 NT$25.2 millionFeb 2025 NT$16 million25/02Mar 2025 NT$27.4 millionApr 2025 NT$36.7 millionMay 2025 NT$28.2 millionJun 2025 NT$25.9 million25/06Jul 2025 NT$25.1 millionAug 2025 NT$17.2 millionSep 2025 NT$26.7 millionOct 2025 NT$27.6 million25/10Nov 2025 NT$24.5 millionDec 2025 NT$28.9 millionJan 2026 NT$25.8 millionFeb 2026 NT$22.3 million26/02Mar 2026 NT$34 millionApr 2026 NT$36.4 millionMay 2026 NT$35.9 millionJun 2026 NT$35.2 million26/06Jul 2026 NT$37.7 millionAug 2026 NT$34 millionSep 2026 NT$34.6 millionOct 2026 NT$40.1 million26/10

Hover over (or tap) a bar to see that month’s revenue.

Monthly revenue history

MonthRevenueYoYMoM
Oct 2026NT$40.1 million+45.4%+15.9%
Sep 2026NT$34.6 million+29.7%+1.7%
Aug 2026NT$34 million+97.4%-9.8%
Jul 2026NT$37.7 million+50.4%+7.0%
Jun 2026NT$35.2 million+35.8%-1.8%
May 2026NT$35.9 million+27.2%-1.4%
Apr 2026NT$36.4 million-1.0%+7.1%
Mar 2026NT$34 million+24.0%+52.2%
Feb 2026NT$22.3 million+40.0%-13.4%
Jan 2026NT$25.8 million+2.1%-10.7%
Dec 2025NT$28.9 million+74.7%+18.1%
Nov 2025NT$24.5 million-30.2%-11.3%
Oct 2025NT$27.6 million-8.4%+3.4%
Sep 2025NT$26.7 million+101.8%+54.8%
Aug 2025NT$17.2 million-20.9%-31.3%
Jul 2025NT$25.1 million+14.2%-3.4%
Jun 2025NT$25.9 million+37.4%-8.0%
May 2025NT$28.2 million-28.1%-23.2%
Apr 2025NT$36.7 million-7.9%+34.0%
Mar 2025NT$27.4 million-20.4%+71.8%
Feb 2025NT$16 million-40.7%-36.8%
Jan 2025NT$25.2 million-36.7%+52.7%
Dec 2024NT$16.5 million-52.8%-52.8%
Nov 2024NT$35.1 million+2.4%+16.6%
Oct 2024NT$30.1 million-4.1%+127.6%

Jan–Oct 2026 cumulative: NT$336 million (+31.2% YoY)

History covers months since this site began collecting, plus prior-month and prior-year figures in each release. It grows every month.

Other Agritech companies

Compare with peers: DaBomb Protein Biotech vs Morn Sun Feed Mill / DaBomb Protein Biotech vs Huikwang / DaBomb Protein Biotech vs GeneReach Biotechnology

CompanyRevenueYoY
Morn Sun Feed Mill1240NT$228 million-3.0%
Huikwang6508NT$114.5 million+42.1%
GeneReach Biotechnology4171NT$21.7 million+12.3%

Company remark (original Chinese)

1.自2022/10以來,單月營收重返4000萬門檻。2.本年度累計營收已達預算目標,並超越去年全年營收。

See also

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16